To include your compound in the COVID-19 Resource Center, submit it here.

TriN 2755: Interim Phase I data

Interim data from 17 evaluable patients in an ongoing, open-label, dose-escalation, German Phase I trial showed that once-monthly

Read the full 181 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE